Revmatismesykehuset AS

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Psoriasis1 trial
• Psoriatic arthritis1 trial
• Rheumatoid arthritis1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 31 trial
• Phase 41 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Diakonhjemmet Hospital1 trial
• Diakonhjemmet Sykehus AS1 trial

Running trials

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcutaneous TNF inhibitor: The Rheumatoid Arthritis therapeutic DRUg Monitoring trial (RA-DRUM)

  2023-510184-35-00· Phase 4· Diakonhjemmet Sykehus AS· Source

• Recruiting

  Imaging Treat-to-target Strategy vs Conventional Treat-to-target Strategy in Psoriatic Arthritis

  NCT05291819· Diakonhjemmet Hospital· Source

  Contact: Yi Hu, MD, PhD

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting